Polarean Imaging plc is a healthcare technology company which has developed a state of the art proprietary drug-device combination addressing a specific global unmet need in the field of healthcare. The company’s technology has been developed over a number of years and provides a visual representation of ventilation and gas exchange in the lungs. Xenon, when polarised in Polarean’s proprietary drug-device system, permits functional, regional and quantitative imaging of the lungs using MRI, without the risk of exposing patients to ionising radiation. The technology is being used in the field of respiratory disease – both in the understanding and treatment of it.
Polarean Imaging plc
Medical drug-device combination company
Company information
Company:
Public
Fund:
EIS Portfolio Service, Growth Capital VCT
Sector:
Biotech, Medical, Pharma, Technology
Status:
Current
Investment Date:
04/2020
You might also be interested in...
Provider of specialist services to the construction and FM markets